Receipt: https://pmc.ncbi.nlm.nih.gov/articles/PMC10692436/ Read: 2026-11-12, curl with browser user agent, HTML converted to text, HTTP 200 Note: Review of oral NR and NMN human trials and their limits. (Text converted from HTML; the superscript plus in NAD+ is joined to the word.) --- Abstract Advancing age and many disease states are associated with declines in nicotinamide adenine dinucleotide (NAD+) levels. Preclinical studies suggest that boosting NAD+ abundance with precursor compounds, such as nicotinamide riboside or nicotinamide mononucleotide, has profound effects on physiological function in models of aging and disease. Translation of these compounds for oral supplementation in humans has been increasingly studied within the last 10 years; however, the clinical evidence that raising NAD+ concentrations can improve physiological function is unclear. The goal of this review was to synthesize the published literature on the effects of chronic oral supplementation with NAD+ precursors on healthy aging and age-related chronic diseases. We identified nicotinamide riboside, nicotinamide riboside co-administered with pterostilbene, and nicotinamide mononucleotide as the most common candidates in investigations of NAD+-boosting compounds for improving physiological function in humans. Studies have been performed in generally healthy midlife and older adults, adults with cardiometabolic disease risk factors such as overweight and obesity, and numerous patient populations. Supplementation with these compounds is safe, tolerable, and can increase the abundance of NAD+ and related metabolites in multiple tissues. Dosing regimens and study durations vary greatly across interventions, and small sample sizes limit data interpretation of physiological outcomes. Limitations are identified and future research directions are suggested to further our understanding of the potential efficacy of NAD+-boosting compounds for improving physiological function and extending human health span. Keywords: Clinical trials, Nicotinamide riboside, Nutrition, Physiology, Successful aging Aging is the primary risk factor for a host of chronic disorders, including cardiovascular and metabolic diseases, chronic kidney disease, Alzheimer’s disease, and related dementias, which represent many of the leading causes of death in developed and developing countries. As the number of older adults rises rapidly, the personal and societal burden of chronic diseases will subsequently grow. This heightens the need for efficacious interventions that can mitigate age-related declines in physiological function by targeting fundamental mechanisms of aging to extend healthspan and reduce morbidity in midlife and older adults. A central molecule in cellular energy metabolism and nutrient sensing is nicotinamide adenine dinucleotide (NAD+), an essential coenzyme in redox reactions and co-substrate for nonredox-related NAD+-dependent enzymes ( 1 ). NAD+ concentrations in humans may be ~10%–80% lower with advancing age ( 2–8 ). Additionally, numerous diseases are associated with reduced NAD+ levels, including metabolic disorders, cancer, and neurodegenerative diseases ( 1 , 9 ). Although such declines in NAD+ levels have not been observed universally across all tissues ( 10 ), the potential benefits of restoring tissue and cellular NAD+ abundance back to young, healthy concentrations on physiological function with aging remain a prevailing question in biomedical research. Promising preclinical findings indicate that increasing NAD+ abundance is causally linked to improvements in physiological function and select markers of healthspan. NAD+ precursors, that is, endogenous molecules involved in the synthesis or regeneration of NAD+ , can improve outcomes such as gluco [...] Abstract Advancing age and many disease states are associated with declines in nicotinamide adenine dinucleotide (NAD+) levels. Preclinical studies suggest that boosting NAD+ abundance with precursor compounds, such as nicotinamide riboside or nicotinamide mononucleotide, has profound effects on physiological function in models of aging and disease. Translation of these compounds for oral supplementation in humans has been increasingly studied within the last 10 years; however, the clinical evidence that raising NAD+ concentrations can improve physiological function is unclear. The goal of this review was to synthesize [...] [...] e compounds for oral supplementation in humans has been increasingly studied within the last 10 years; however, the clinical evidence that raising NAD+ concentrations can improve physiological function is unclear. The goal of this review was to synthesize the published literature on the effects of chronic oral supplementation with NAD+ precursors on healthy aging and age-related chronic diseases. We identified nicotinamide riboside, nicotinamide riboside co-administered with pterostilbene, and nicotinamide mononucleotide as the most common candidates in investigations of NAD+-boosting compounds for improving physiological function in humans. Studies have been performed in generally healthy midlife and older adults, adults with cardiometabolic disease risk factors such as overweight and obesity, and numerous patient populations. Supplementation with these compounds is safe, tolerable, and can increase the abundance of NAD+ and related metabolites in multiple tissues. Dosing regimens and study durations vary greatly across interventions, and small sample sizes limit data interpretation of physiological outcomes. Limitations are ident [...] [...] otinamide riboside co-administered with pterostilbene, and nicotinamide mononucleotide as the most common candidates in investigations of NAD+-boosting compounds for improving physiological function in humans. Studies have been performed in generally healthy midlife and older adults, adults with cardiometabolic disease risk factors such as overweight and obesity, and numerous patient populations. Supplementation with these compounds is safe, tolerable, and can increase the abundance of NAD+ and related metabolites in multiple tissues. Dosing regimens and study durations vary greatly across interventions, and small sample sizes limit data interpretation of physiological outcomes. Limitations are identified and future research directions are suggested to further our understanding of the potential efficacy of NAD+-boosting compounds for improving physiological function and extending human health span. Keywords: Clinical trials, Nicotinamide riboside, Nutrition, Physiology, Successful aging Aging is the primary risk factor for a [...] [...] tinamide adenine dinucleotide (NAD+) levels. Preclinical studies suggest that boosting NAD+ abundance with precursor compounds, such as nicotinamide riboside or nicotinamide mononucleotide, has profound effects on physiological function in models of aging and disease. Translation of these compounds for oral supplementation in humans has been increasingly studied within the last 10 years; however, the clinical evidence that raising NAD+ concentrations can improve physiological function is unclear. The goal of this review was to synthesize the published literature on the effects of chronic oral supplementation with NAD+ precursors on healthy aging and age-related chronic diseases. We identified nicotinamide riboside, nicotinamide riboside co-administered with pterostilbene, and nicotinamide mononucleotide as the most common candidates in investigations of NAD+-boosting compounds for improving physiological function in humans. Studies have been performed in generally healthy midlife and o [...]